Ulcerative Colitis - Page 8 
The MD Magazine Ulcerative Colitis condition center provides clinical news and articles, information about upcoming conferences and meetings, updated clinical trial listings, and other resources.


Putting a Price Tag on Crohn's
Medical economists estimate Crohn's disease is responsible for $3.48 billion in total national costs (expected to increase to $3.72 billion in 2025).
The presence of anti-microbial antibodies that have accumulated for years before a person is diagnosed with Crohn’s disease spells complications and a difficult course of treatment.
During a fecal matter transfer (FMT), non-pathogenic viruses were transferred from a healthy patient to three pediatric ulcerative colitis (UC) patients, according to findings published in mBio.
Rare structural variants in genes could be contributing to the pathogenesis of ulcerative colitis.
Using a minimally invasive screening method for ulcerative colitis (UC) is a quick and cost-effective approach to disease detection.
Anorexia nervosa, chronic fatigue syndrome, and irritable bowel syndrome (IBS) might not be the typical threesome, but these three conditions do share a common origin.
The FDA has approved Inflectra (infliximab-dyyb/Celltrion, Inc), the biosimilar for Remicade (infliximab) for the treatment of patients suffering from serious autoimmune diseases.
Autoimmune diseases like rheumatoid arthritis (RA) and Crohn’s disease are “gonna be defeated”, according to findings published in the Proceedings of the National Academy of Sciences.
The field of gastroenterology is as wide as the the amount of the body that it covers. Because of this there are certain challenges doctors face whether they treat the entire gastrointestinal system or just specific parts.

Most Popular


$vacMongoViewPlus$ $vAR$